Supriya Patel

Title: Supriya Patel: Innovator in Antigen Binding Molecules

Introduction

Supriya Patel is a prominent inventor based in Mamaroneck, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of antigen binding molecules. With a total of 11 patents to her name, Patel is recognized for her innovative approaches to cancer treatment.

Latest Patents

Patel's latest patents focus on antigen binding molecules (ABMs) that comprise Fab domains in non-native configurations. These patents include ABM conjugates that combine the ABMs with cytotoxic or cytostatic agents. Additionally, her work encompasses pharmaceutical compositions containing the ABMs and ABM conjugates, as well as methods for using these compositions in cancer treatment. Her patents also cover nucleic acids encoding the ABMs, cells engineered to express the ABMs, and methods for producing these innovative molecules.

Career Highlights

Supriya Patel is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to advance her research in the field. Her work has garnered attention for its potential impact on cancer therapies and has positioned her as a leader in her area of expertise.

Collaborations

Patel collaborates with notable colleagues, including Samuel H. Davis and Eric L. Smith, to further enhance her research and development efforts. These collaborations contribute to the innovative environment at Regeneron Pharmaceuticals.

Conclusion

Supriya Patel's contributions to the field of antigen binding molecules exemplify her dedication to advancing cancer treatment. Her innovative patents and collaborative efforts highlight her role as a key figure in biotechnology.